Search results for "BOS"
showing 10 items of 3713 documents
Field and microcosm experiments to evaluate the effects of agricultural Cu treatment on the density and genetic structure of microbial communities in…
2006
The effects of Cu amendment on indigenous soil microorganisms were investigated in two soils, a calcareous silty clay (Ep) and a sandy soil (Au), by means of a 1-year field experiment and a two-month microcosm incubation. Cu was added as 'Bordeaux mixture' [CuSO(4), Ca(OH)(2)] at the standard rate used in viticulture (B1=16 kg Cu kg(-1) soil) and at a higher level of contamination (B3=48 kg Cu ha(-1) soil). More extractable Cu was observed in sandy soil (Au) than in silty soil (Ep). Furthermore, total Cu and Cu-EDTA declined with time in Au soil, whereas they remained stable in Ep soil. Quantitative modifications of the microflora were assessed by C-biomass measurements and qualitative modi…
Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness
2020
Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by T…
2021
The Millennial Generation of Thrombosis and Hemostasis
2020
Atypical thrombosis associated with VaxZevria (R) (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
2021
The current COVID-19 pandemic is an exceptional health situation including for drug use. As there was no known effective drug for COVID-19 at the beginning of the pandemic, different candidates were proposed. In this short article, we present the French public pharmacovigilance activities during this health crisis. Although COVID-19 is a confounding factor per se, owing to its potential for multi-organ damage including the heart and kidney, the quality of the transmitted data in adverse drug reaction reports, the timeliness of feedback from clinicians, and the real-time pharmacological and medical analysis by the French network of the regional pharmacovigilance centers made it possible to s…
"Table 12: Cross-section limits lepton specific tanb 1" of "Search for a heavy Higgs boson decaying into a $Z$ boson and another heavy Higgs boson in…
2018
The cross section times BR(A->ZH) times BR(H->bb) limits for an A boson in the lepton specific, tanbeta 1, 2HDM. For each signal point, characterised by the mass pair (mA, mH), two limits are provided, the observed and the expected. The correct width as predicted by this particular parameter choice of the 2HDM is used. For lepton specific only gluon-gluon fusion is used and the nb=2 category only.
"Table 14: Cross-section limits lepton specific tanb 3" of "Search for a heavy Higgs boson decaying into a $Z$ boson and another heavy Higgs boson in…
2018
The cross section times BR(A->ZH) times BR(H->bb) limits for an A boson in the lepton specific, tanbeta 3, 2HDM. For each signal point, characterised by the mass pair (mA, mH), two limits are provided, the observed and the expected. The correct width as predicted by this particular parameter choice of the 2HDM is used. For lepton specific only gluon-gluon fusion is used and the nb=2 category only.
"Table 13: Cross-section limits lepton specific tanb 2" of "Search for a heavy Higgs boson decaying into a $Z$ boson and another heavy Higgs boson in…
2018
The cross section times BR(A->ZH) times BR(H->bb) limits for an A boson in the lepton specific, tanbeta 2, 2HDM. For each signal point, characterised by the mass pair (mA, mH), two limits are provided, the observed and the expected. The correct width as predicted by this particular parameter choice of the 2HDM is used. For lepton specific only gluon-gluon fusion is used and the nb=2 category only.
Baltu filoloģija, 23. sēj., Nr.1
2014
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents
2019
Type 2 diabetes mellitus (T2DM) is an important metabolic disorder for which there is an urgent need for new antidiabetic drugs. α-Glucosidase inhibition is an established protocol for T2DM therapy. Because hyperglycemia causes oxidative tissue damage, the development of agents with both α-glucosidase inhibition and antioxidant activity from natural or natural-derived polyphenols such derivatives of rosmarinic acid (RA) represents an attractive therapeutic option. We report a study on amides 1-10 derived from RA and their evaluation for yeast α-glucosidase inhibition and antioxidant activity (DPPH and ORAC tests). All amides showed higher inhibitory activity than that of RA, were by far mor…